SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Scope & Guideline

Fostering Insights for Enhanced Patient Outcomes

Introduction

Welcome to the SCANDINAVIAN JOURNAL OF RHEUMATOLOGY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0300-9742
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1959 to 1962, 1964, from 1972 to 2024
AbbreviationSCAND J RHEUMATOL / Scand. J. Rheumatol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The Scandinavian Journal of Rheumatology focuses on advancing the knowledge and treatment of rheumatic diseases through high-quality research and clinical studies. Its primary aims and scopes encompass a wide range of topics related to rheumatology, emphasizing the need for evidence-based practices and innovative treatment approaches.
  1. Rheumatic Disease Mechanisms:
    The journal extensively covers the underlying mechanisms of various rheumatic diseases, including autoimmune responses, genetic predispositions, and inflammatory pathways.
  2. Clinical Trials and Treatment Efficacy:
    A significant focus is placed on clinical trials evaluating the efficacy and safety of new and existing treatments for rheumatic diseases, including biologics and novel therapeutic agents.
  3. Patient-Centered Research:
    Research that highlights patient-reported outcomes, quality of life, and the psychosocial aspects of living with rheumatic diseases is a core area of interest, promoting a holistic approach to treatment.
  4. Innovative Diagnostic Techniques:
    The journal publishes studies on new diagnostic methods, including imaging techniques and biomarkers, aimed at improving the diagnosis and monitoring of rheumatic conditions.
  5. Epidemiological Studies:
    Epidemiological research assessing the prevalence, incidence, and risk factors associated with rheumatic diseases is prominently featured, contributing to a better understanding of these conditions.
  6. Interdisciplinary Approaches:
    The journal encourages interdisciplinary research that integrates perspectives from various fields, including immunology, genetics, and rehabilitation sciences, to enhance the understanding and management of rheumatological disorders.
The Scandinavian Journal of Rheumatology has seen a notable shift towards emerging themes that reflect current trends in rheumatology research. These themes not only enhance the understanding of rheumatic diseases but also align with advancements in medical science and patient care.
  1. Digital Health and Telemedicine:
    There is a growing emphasis on digital health interventions and telemedicine, particularly in the context of managing chronic rheumatic diseases during and post-COVID-19, showcasing the adaptation of healthcare practices.
  2. Personalized Medicine and Biomarkers:
    Research focusing on personalized medicine, including the identification of biomarkers for treatment responses and disease progression, is increasingly highlighted, reflecting a trend towards tailored therapies.
  3. Comorbidities and Multidisciplinary Care:
    Studies examining the impact of comorbidities on rheumatic diseases and the importance of multidisciplinary care approaches are gaining traction, emphasizing the need for comprehensive patient management.
  4. Longitudinal and Real-World Data Studies:
    There is a trend towards the use of longitudinal studies and real-world data analyses to assess treatment outcomes and disease progression in diverse populations, providing valuable insights into long-term management.
  5. Psychosocial Aspects of Rheumatic Diseases:
    Research exploring the psychological and social factors affecting patients with rheumatic diseases is emerging, indicating a shift towards understanding the holistic impact of these conditions on patients' lives.

Declining or Waning

While the Scandinavian Journal of Rheumatology continues to grow in various research areas, certain themes have seen a decline in prominence over recent years. This may indicate evolving interests within the field or shifts towards more impactful research questions.
  1. Traditional Pharmacotherapy:
    Research focusing solely on traditional pharmacotherapy options, such as NSAIDs and corticosteroids, appears to be waning as newer biologic and targeted therapies gain prominence.
  2. Case Reports and Isolated Incidents:
    The publication of individual case reports has decreased, possibly due to a shift towards larger cohort studies and clinical trials that provide more generalized data and insights.
  3. Basic Science and Laboratory Studies:
    There seems to be a decline in purely laboratory-based studies that do not directly translate into clinical practice, as the journal emphasizes translational research that bridges the gap between laboratory findings and patient care.

Similar Journals

Rheumatology Advances in Practice

Transforming insights into practice for rheumatology professionals.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 2 issues/year

Rheumatology Advances in Practice, published by Oxford University Press, is a vital open-access journal dedicated to advancing research and education in the field of rheumatology. With an E-ISSN of 2514-1775 and an impressive open access model established since 2017, this journal facilitates the dissemination of cutting-edge knowledge and innovative practices to a global audience. It has garnered recognition within the academic community, holding a Q3 classification in Rheumatology for 2023, which reflects its contribution to the evolving landscape of rheumatological research. The journal aims to present high-quality, peer-reviewed articles that explore the latest findings, advancements, and clinical applications in rheumatology, making it an essential resource for researchers, healthcare professionals, and students alike. By bridging the gap between research and practice, Rheumatology Advances in Practice plays a significant role in improving the care of patients with rheumatological conditions, promoting evidence-based approaches to clinical challenges.

Reumatologia

Empowering healthcare through open access research.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 0034-6233Frequency: 6 issues/year

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.

Open Access Rheumatology-Research and Reviews

Empowering Researchers with Open Access Insights.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-156XFrequency: 1 issue/year

Open Access Rheumatology-Research and Reviews, published by DOVE MEDICAL PRESS LTD, is a distinguished journal that has been a vital part of the rheumatology field since its inception in 2009. With an ISSN of 1179-156X, this journal is dedicated to disseminating groundbreaking research and comprehensive reviews in the discipline of rheumatology, making it an essential resource for researchers, clinicians, and students alike. It boasts an impressive Q3 ranking in the Rheumatology category for 2023, reflecting its relevance and quality within a highly competitive landscape, where it ranks in the 51st percentile among its peers as indicated by the Scopus Ranks. As an open-access platform, it ensures that critical findings and insights are easily accessible to a global audience, promoting collaboration and knowledge sharing. The journal's scope includes a wide range of topics within rheumatology, aimed at advancing understanding and treatment of musculoskeletal disorders and autoimmune diseases. Its headquarters is located in New Zealand, positioning it as a key player in the international research community.

Egyptian Rheumatology and Rehabilitation

Empowering healthcare through innovative research.
Publisher: SPRINGERNATUREISSN: 1110-161XFrequency: 1 issue/year

Egyptian Rheumatology and Rehabilitation is a distinguished open-access journal published by SpringerNature, dedicated to the vital field of rheumatology and rehabilitation. With an E-ISSN of 2090-3235 and a commitment to disseminating high-quality research, this journal serves as a platform for researchers, clinicians, and healthcare professionals to share innovative findings and enhance patient care in musculoskeletal disorders and related conditions. Since its transition to open access in 2013, the journal has prioritized accessibility, allowing a wider audience to engage with groundbreaking studies and clinical insights. By fostering a collaborative environment for knowledge exchange, Egyptian Rheumatology and Rehabilitation plays a crucial role in advancing the understanding of rheumatic diseases and improving rehabilitation strategies. The journal's commitment to quality and relevance in the evolving landscape of rheumatology makes it an invaluable resource for those pursuing excellence in research and practice.

Modern Rheumatology

Navigating the Frontiers of Rheumatology
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

Arthritis & Rheumatology

Fostering Insights for a Healthier Tomorrow
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

RHEUMATOLOGY INTERNATIONAL

Elevating the standards of rheumatological science.
Publisher: SPRINGER HEIDELBERGISSN: 0172-8172Frequency: 12 issues/year

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

SEMINARS IN ARTHRITIS AND RHEUMATISM

Exploring innovative therapies for better patient outcomes.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0049-0172Frequency: 6 issues/year

SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.

AKTUELLE RHEUMATOLOGIE

Shaping the future of rheumatology with impactful studies.
Publisher: GEORG THIEME VERLAG KGISSN: 0341-051XFrequency: 6 issues/year

AKTUELLE RHEUMATOLOGIE is a prominent German journal published by GEORG THIEME VERLAG KG, dedicated to advancing the field of rheumatology. Since its inception in 1978, this peer-reviewed journal has been a vital resource for professionals, researchers, and students engaged in the study and treatment of rheumatic diseases. With an ISSN of 0341-051X and an E-ISSN of 1438-9940, the journal provides a platform for sharing groundbreaking research, clinical studies, and reviews. Although classified in the fourth quartile (Q4) of rheumatology journals and ranked 67 out of 73 in its category according to Scopus, AKTUELLE RHEUMATOLOGIE continues to contribute to the discourse in rheumatology. Its comprehensive coverage of recent advancements and innovative approaches makes it an essential publication for anyone interested in the latest developments in the field.

Reumatologia Clinica

Empowering insights into rheumatic diseases.
Publisher: ELSEVIER ESPANA SLUISSN: 1699-258XFrequency: 6 issues/year

Reumatologia Clinica is a distinguished journal dedicated to the field of Rheumatology, published by Elsevier España SLU. With its ISSN of 1699-258X and E-ISSN 1885-1398, the journal aims to disseminate pivotal research findings and clinical studies from 2005 to 2024, spotlighting advancements in the understanding and treatment of rheumatic diseases. Based in Barcelona, Spain, it plays a vital role in the academic community, ranking in the Q3 category for Rheumatology as of 2023, with a Scopus ranking of #44 out of 73, placing it in the 40th percentile. Although it operates under a traditional access model, the journal is committed to academic excellence, providing researchers, healthcare professionals, and students with invaluable insights that drive the field forward. Reumatologia Clinica serves as an essential resource for those looking to deepen their knowledge and contribute to the evolving landscape of rheumatologic research.